Research Scientist - Product Development (Life Sciences)

Job Location
Cambridge, UK
United Kingdom

Onsite gym

Onsite restaurant


Job Description


Research Scientist - Product Development (Life Sciences)

Temporary (12 month contract)


Cambridgeshire, UK



Fantastic opportunity for an experience degree qualified biological scientist who has a multi-disciplinary background, and wants the opportunity to work in a multidisciplinary team developing new technologies for the next generation sequencing market.


Illumina is the global leader in Next Generation Sequencing (NGS) technology and their key platforms encompass technologies across biotechnology, physics, engineering, materials science and software.

The Technology Development team is looking for a Product Development Scientist (with a multi-disciplinary background) to be part of a multidisciplinary team focussed on the development and integration of innovative new chemistry, microbiology and engineering technologies to deliver innovative new solutions to support Illumina’s position as market leader in NGS.   

The incumbent would be joining a multidisciplinary team, which is part of a larger super-group of 30+ engineers and scientists whose function is to identify and develop Illumina’s NGS product offering – this function is at the heart of Illumina’s success.

Job duties include but are not limited to:


  • Identifying and pursuing opportunities to develop new technology and business opportunities through individual and team creativity
  • Developing new workflows to exploit new technologies and optimise technology/assay performance
  • Hands-on product development and design of novel solutions to complex mechanical, fluidic and manufacturing problems
  • Taking the technical lead on projects working closely within teams of scientists and engineers
  • Providing major input to identification of technical challenges and solutions
  • Delivering technical reports and producing high quality design documentation
  • Generating high quality analysis work autonomously


This is a fantastic opportunity to help shape the future of Illumina, by identifying and developing novel technologies key to Illumina's strategic business plan.  This would suit a candidate that has a background in product development, within the life science/diagnostics or similar market, who enjoys identifying cutting-edge technology at its early stages and developing them into truly innovative products.





  • Talented, creative Biological Scientist, with excellent analytical, practical and creative skills
  • A broad range of technical competencies that span fields like molecular biology, automation, microfluidics, system development etc…
  • MSc/PhD in relevant subject area
  • Proven experience working in a commercial environment
  • Adept at balancing technical ambitions against practical constraints
  • Good market awareness, with keen interest and capability in identifying new market opportunities for technology
  • Very good communication and team skills, including working in multi-disciplinary science and engineering teams
  • Highly desirable: Participation in, or exposure to, the development of innovative medical devices and equipment from concept to prototype manufacture
  • Highly desirable: knowledge of manufacture and assembly processes, from one off designs to high volume manufacture
How to Apply

Interested parties should apply through Illumina’s career website using the reference 3703BR.

About Our Organization

All About Us


Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.


lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.9 billion in 2014. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review.  As of December 2014, the company had a $26 billion market capitalization.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.